Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

REFILE-World risks 'moral catastrophe' if COVID shots delayed in Africa, its CDC chief says

Published 05/01/2021, 10:17
Updated 05/01/2021, 10:18
© Reuters

(Refiles Dec. 31 story adding co-leaders of COVAX programme in
paragraph 10)
NAIROBI, Dec 31 (Reuters) - The world risks a "moral
catastrophe" if COVID-19 vaccinations are delayed in Africa
while wealthier regions inoculate their entire populations, the
head of the continent's disease control body said on Thursday.
The Africa Centres for Disease Control and Prevention (CDC)
hopes significant vaccination campaigns on the continent will
begin in April, its head, John Nkengasong, told reporters.
"That's a long way to go given that this virus transmits
very quickly," he said, adding that in Africa, "the second wave
is here with a vengeance".
Cases of the new coronavirus increased by nearly 19% since
last week and deaths increased by 26%, according to Africa CDC
data. Africa has recorded 2.7 million coronavirus infections and
64,000 deaths as of Thursday, it says.
South Africa, where a new variant of the virus has been
detected, recorded 82,000 cases in the past week, he said.
"We cannot delay, we need those vaccines and need them now,"
Nkengasong said.
The major blockers to vaccinations beginning in Africa are
global availability of doses and financing, he said.
Wealthy nations have acquired vaccines in excess of what
they need, he said.
"We don't have to get into a moral crisis, where these
things are stocked in the developed world and we in Africa are
struggling to have," Nkengasong said.
The African Union is in talks with the European Union,
Canada and pharmaceutical companies to secure vaccines, he said,
in addition to what Africa has been promised by the COVAX
programme, co-led by the World Health Organization, Gavi the
Vaccine Alliance and the Coalition for Epidemic Preparedness
Innovations. COVAX is a global scheme to deliver COVID-19
vaccines to poorer countries
"This would easily become a moral catastrophe if we should
not come together as one to address going forward as early as
possible in 2021 and meet Africa at its point of need."
Approval processes for various vaccines will likely be
fast-tracked through a central African Union process, he said.
A handful of nations on the continent are further along.
Morocco said earlier this month it plans to roll out China's
Sinopharm vaccine within weeks as soon as its Phase 3 trials are
over, while Egypt received its first shipment of Sinopharm
vaccines on Dec.11. L1N2IO22Z L8N2IQ70D
South Africa expects to get the COVAX vaccine by the second
quarter of 2021, President Cyril Ramaphosa said on Monday. The
COVAX alliance said on Dec. 18 its first deliveries were due in
early 2021, without giving a specific date. African governments should learn the lesson that local
manufacturing of vaccines and strong testing capacities are
critical, Nkengasong said, noting that the continent faced the
same scenario of a scramble for vaccines - and Western nations
far ahead - more than a decade ago during the H1N1 swine flu
outbreak.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
South Africa to get firm date on delivery of vaccine by early
January, experts say ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.